IndraLab

Statements

Gallic acid inhibits STAT1. 4 / 4
| 4
reach
"Glatiramer acetate (GA), a FDA approved treatment for MS, was shown to promote activation of anti-inflammatory monocytes by reducing STAT1 signaling."
27713030
reach
"These results suggest that GA could inhibit the activations of STAT1 and -3 in PBMCs, in addition to brain resident immune cells."
28094337
reach
"GA attenuates the STAT1 and -3 signaling in peripheral blood mononuclear cells, but not neuronal cells."
28094337
reach
"These results indicate that the ability of GA to inhibit the activations of STAT1 and -3 is not mediated through IFNgamma -/- or IFNgammaR -/- system."
28094337